What Is Driving the Growth of the Global Sequencing Consumables Market?

Sequencing Consumables Market

The global sequencing consumables market is experiencing remarkable growth due to increasing adoption of next-generation sequencing (NGS), expanding genomics research, and rising demand for precision medicine. The global sequencing consumables market size is valued at USD 10.25 billion in 2025 and is estimated to reach USD 62.90 billion by 2034, growing at a CAGR of 22.37% during the forecast period (2026–2034).

Sequencing consumables include reagents, library preparation kits, sample preparation kits, flow cells, sequencing chips, buffers, and other essential materials used throughout DNA and RNA sequencing workflows. Growing demand for low-input library preparation consumables capable of delivering high-fidelity sequencing results is significantly accelerating market growth. Increasing applications in oncology, infectious disease diagnostics, reproductive health, agriculture, and drug discovery continue expanding the global demand for sequencing consumables.

For detailed market insights, growth forecasts, and competitive analysis, visit:

https://straitsresearch.com/report/sequencing-consumables-market

Market Drivers

Rising Adoption of Next-Generation Sequencing

Next-generation sequencing technologies are becoming increasingly important in clinical diagnostics, biomedical research, and personalized medicine. The growing use of NGS for whole-genome sequencing, targeted sequencing, transcriptomics, and epigenetics is driving continuous demand for high-quality sequencing consumables.

Healthcare providers and research institutions continue investing heavily in advanced sequencing platforms.

Growing Demand for High-Fidelity Library Preparation

Researchers increasingly require low-input library preparation consumables that deliver greater sequencing accuracy, higher sensitivity, and reduced sample loss. Advanced consumables improve sequencing efficiency while supporting applications involving limited or degraded biological samples.

Continuous innovation in library preparation technologies is strengthening market growth.

Expansion of Precision Medicine and Genomics Research

Precision medicine relies heavily on genomic sequencing for disease diagnosis, biomarker identification, and personalized treatment selection. Governments, pharmaceutical companies, and research organizations continue expanding investments in genomics research and large-scale sequencing projects.

Growing clinical adoption of genomic testing continues fueling market demand.

Market Challenges

High Cost of Sequencing Workflows

Although sequencing costs have declined significantly, advanced sequencing consumables remain relatively expensive for many laboratories and healthcare providers. Budget limitations may restrict widespread adoption in developing regions.

Manufacturers continue developing cost-effective consumable solutions to improve accessibility.

Quality Control and Regulatory Compliance

Sequencing consumables must meet strict quality standards to ensure reproducibility, sequencing accuracy, and regulatory compliance. Manufacturers must continuously invest in quality assurance and product validation.

Reliable consumables remain essential for accurate genomic analysis.

Market Segmentation

By Product

The market is segmented into library preparation kits, sample preparation kits, sequencing reagents, flow cells, sequencing chips, buffers, enzymes, and other consumables. Sequencing reagents and library preparation kits account for the largest market share due to their recurring use across genomic sequencing workflows.

Flow cells and sequencing chips continue witnessing strong demand with increasing NGS adoption.

By Technology

The market includes next-generation sequencing, Sanger sequencing, third-generation sequencing, and other sequencing technologies. Next-generation sequencing dominates the market owing to its high throughput, improved accuracy, and broad clinical applications.

Third-generation sequencing is expected to witness rapid growth as long-read sequencing technologies continue advancing.

By Application

The market serves oncology, infectious disease diagnostics, reproductive health, genetic disease research, drug discovery, agriculture, microbiology, and precision medicine. Oncology represents the largest application segment due to increasing use of genomic sequencing for cancer diagnosis and personalized treatment.

Infectious disease surveillance and precision medicine are also experiencing significant growth.

By End User

Major end users include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, academic research institutes, and contract research organizations. Pharmaceutical and biotechnology companies account for a substantial market share due to expanding investments in genomics-based drug development.

Academic research institutions continue driving innovation in sequencing technologies.

Regional Insights

North America

North America dominates the sequencing consumables market due to advanced genomics research infrastructure, widespread adoption of next-generation sequencing, strong biotechnology industries, and significant government funding. The United States remains the leading regional market.

Europe

Europe represents a major market supported by increasing investments in precision medicine, expanding genomic research programs, and growing clinical sequencing adoption. Germany, the United Kingdom, France, and Switzerland remain major contributors.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth during the forecast period. Rising healthcare investments, expanding biotechnology industries, increasing genomic research activities, and growing government support for precision medicine are driving demand across China, India, Japan, South Korea, and Singapore.

Rapid expansion of sequencing laboratories continues strengthening regional growth.

Latin America, Middle East & Africa

These regions are gradually expanding genomic research capabilities through increasing healthcare investments, international collaborations, and modernization of laboratory infrastructure. Growing awareness of precision diagnostics is expected to create future market opportunities.

Key Players Analysis

The sequencing consumables market is highly competitive, with leading companies focusing on innovative reagents, advanced library preparation kits, automated sample preparation solutions, and high-performance sequencing consumables. Manufacturers continue investing in research and development, strategic partnerships, and product innovation to strengthen their competitive positions.

Automation, AI-assisted genomics, and next-generation sequencing workflows are expected to drive future market expansion.

Key Companies

• Illumina, Inc.

• Thermo Fisher Scientific Inc.

• F. Hoffmann-La Roche Ltd.

• QIAGEN N.V.

• Pacific Biosciences

• Oxford Nanopore Technologies plc

• Agilent Technologies, Inc.

• Revvity, Inc.

• Bio-Rad Laboratories, Inc.

• Takara Bio Inc.

Conclusion

The global sequencing consumables market is expected to witness exceptional growth through 2034, driven by increasing adoption of next-generation sequencing, expanding precision medicine initiatives, and growing demand for high-fidelity sequencing workflows. Although sequencing costs and regulatory requirements remain key challenges, continuous technological innovation and expanding genomics research are expected to create significant growth opportunities. As genomic medicine becomes increasingly integrated into clinical practice, sequencing consumables will remain fundamental to modern molecular diagnostics and life sciences research.

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: [email protected]

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)